RA is associated with an augmented expression of the receptor activator of RANKL (receptor activator of nuclear factor kappa–B ligand, NF-KB ligand) and low levels of its antagonist, osteoprotegerin (OPG) [7]. The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.